LINDSEY WILSON: Open Payments
NPI 1619236981 · SPRINGDALE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 19 payments from 15 companies in 2025. Trend: 2023 $157 · 2024 $58 · 2025 $457
Food & beverage: $407Education: $50
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 1 | $121 |
| Gilead Sciences, Inc. | 1 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| JAZZ PHARMACEUTICALS INC. | 3 | $42 |
| ABBVIE INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $32 |
| Janssen Biotech, Inc. | 1 | $18 |
| Aveo Pharmaceuticals, Inc. | 1 | $15 |
| Incyte Corporation | 1 | $15 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: BESREMI, Trodelvy, KISQALI, ELAHERE, VERZENIO, ZIIHERA, RYBREVANT, FOTIVDA.
Industry payments across AR — which companies pay providers there.
